1° GIORNATA BERGAMASCA DI RADIOTERAPIA ONCOLOGICA: DALLE TECNOLOGIE AVANZATE AL TRATTAMENTO PERSONALIZZATO

1. 1.Soo-Ryum Yang et al. Precision medicine in non-small cell lung cancer: Current applications and future directions Seminars in Cancer Biology. Volume 84, September 2022, Pages 184-198. 2002
   Articolo scientificoVolume 84, September 2022, Pages 184-198Leggi il paperCerca versione gratuita
2. 2.Umberto Malapelle et al. The evolving role of liquid biopsy in lung cancer.. Lung Cancer Volume 172, October 2022, Pages 53-64. 2002
   Articolo scientificoLung Cancer Volume 172, October 2022, Pages 53-64Leggi il paperCerca versione gratuita
3. 3.Wang H, Liu X, Song Y, Yin P, Zou J, Shi X, Yin Y, Li Z.. Feasibility study of adaptive radiotherapy for esophageal cancer using artificial intelligence autosegmentation based on MR-Linac.. Front Oncol. 2023 Jun 8;13:1172135. doi: 10.3389/fonc.2023.1172135. PMID: 37361583; PMCID: PMC10289262.. 2023
   Articolo scientificoFront Oncol. 2023 Jun 8;13:1172135. doi: 10.3389/fonc.2023.1172135. PMID: 37361583; PMCID: PMC10289262.Leggi il PDF gratuito
4. 4.Zhao Y, Wang H, Yu C, Court LE, Wang X, Wang Q, Pan T, Ding Y, Phan J, Yang J.. Compensation cycle consistent generative adversarial networks (Comp-GAN) for synthetic CT generation from MR scans with truncated anatomy.. Med Phys. 2023 Jul;50(7):4399-4414. doi: 10.1002/mp.16246. Epub 2023 Feb 4. PMID: 36698291; PMCID: PMC10356747. 2023
   Articolo scientificoMed Phys. 2023 Jul;50(7):4399-4414. doi: 10.1002/mp.16246. Epub 2023 Feb 4. PMID: 36698291; PMCID: PMC10356747Leggi il PDF gratuito
5. 5.Liu, H., Schaal, D., Curry, H. et al.. Review of cone beam computed tomography based online adaptive radiotherapy: current trend and future direction. Radiat Oncol 18, 144 (2023). https://doi.org/10.1186/s13014-023-02340-2. 2023
   Articolo scientificoRadiat Oncol 18, 144 (2023). https://doi.org/10.1186/s13014-023-02340-2Leggi il PDF gratuito
6. 6.Landry G, Kurz C, Traverso A.. The role of artificial intelligence in radiotherapy clinical practice. BJR Open. 2023 Oct 18;5(1):20230030. doi: 10.1259/bjro.20230030. PMID: 37942500; PMCID: PMC10630974.. 2023
   Articolo scientificoBJR Open. 2023 Oct 18;5(1):20230030. doi: 10.1259/bjro.20230030. PMID: 37942500; PMCID: PMC10630974.Leggi il PDF gratuito
7. 7.Bodensohn R, Maier SH, Belka C, Minniti G, Niyazi M.. Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques.. Cancers (Basel). 2023 Nov 14;15(22):5404. doi: 10.3390/cancers15225404. PMID: 38001664; PMCID: PMC10670108.. 2023
   Articolo scientificoCancers (Basel). 2023 Nov 14;15(22):5404. doi: 10.3390/cancers15225404. PMID: 38001664; PMCID: PMC10670108.Leggi il PDF gratuito
8. 8.Bodensohn R, Kaempfel AL, Boulesteix AL, Orzelek AM, Corradini S, Fleischmann DF, Forbrig R, Garny S, Hadi I, Hofmaier J, Minniti G, Mansmann U, Pazos Escudero M, Thon N, Belka C, Niyazi M.. Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: A nonrandomized controlled trial.. Radiother Oncol. 2023 Sep;186:109744. doi:10.1016/j.radonc.2023.109744. Epub 2023 Jun 15. PMID: 37330054.. 2023
   Articolo scientificoRadiother Oncol. 2023 Sep;186:109744. doi:10.1016/j.radonc.2023.109744. Epub 2023 Jun 15. PMID: 37330054.Leggi il PDF gratuito
9. 9.Palmer JD, Trifiletti DM, Gondi V, Chan M, Minniti G, Rusthoven CG, Schild SE, Mishra MV, Bovi J, Williams N, Lustberg M, Brown PD, Rao G, Roberge D.. Multidisciplinary patient-centered management of brain metastases and future directions.. Neurooncol Adv. 2020 Mar 16;2(1):vdaa034. doi:10.1093/noajnl/vdaa034. PMID: 32793882; PMCID: PMC7415255.. 2020
   Articolo scientificoNeurooncol Adv. 2020 Mar 16;2(1):vdaa034. doi:10.1093/noajnl/vdaa034. PMID: 32793882; PMCID: PMC7415255.Leggi il PDF gratuito
10. 10.Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P,Weller M, Preusser M; EANO Executive Board and ESMO Guidelines Committee. Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.. Ann Oncol. 2021 Nov;32(11):1332-1347. doi:10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6. PMID: 34364998. 2021
    Articolo scientificoAnn Oncol. 2021 Nov;32(11):1332-1347. doi:10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6. PMID: 34364998Leggi il PDF gratuito
11. 11.Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N, Jakola AS, Niyazi M, Smits M, Verger A, Cicone F, Weller M, Preusser M; European. Organisation for Research and Treatment of Cancer Brain Tumor Group. Translating the theranostic concept to neuro-oncology: disrupting barriers.. Lancet Oncol2024 Sep;25(9):e441-e451. doi: 10.1016/S1470-2045(24)00145-1. PMID: 39214115.. 2024
    Articolo scientificoLancet Oncol2024 Sep;25(9):e441-e451. doi: 10.1016/S1470-2045(24)00145-1. PMID: 39214115.Leggi il PDF gratuito
12. 12.: Nicosia L, Figlia V, Giaj-Levra N, Minniti G, Alongi F. Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases: is it time to give up whole-brain radiotherapy?. Oncoscience. 2020 Apr 24;7(3-4):19-20.. 2020
    Articolo scientificoOncoscience. 2020 Apr 24;7(3-4):19-20.Leggi il PDF gratuito
13. 13.Tini P, Marampon F, Giraffa M, Bucelli S, Niyazi M, Belka C, Minniti G.. Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov.. Radiat Oncol. 2023 Apr 4;18(1):62.doi: 10.1186/s13014-023-02243-2. PMID: 37016421; PMCID: PMC10074717.. 2023
    Articolo scientificoRadiat Oncol. 2023 Apr 4;18(1):62.doi: 10.1186/s13014-023-02243-2. PMID: 37016421; PMCID: PMC10074717.Leggi il PDF gratuito
14. 14.Navarria P, Pessina F, Minniti G, Franzese C, Marini B, D'agostino G, Badalamenti M, Raspagliesi L, Reggiori G, Lobefalo F, Fariselli L, Franceschini D, Bellu L, Clerici E, Pinzi V, Scorsetti M. Multimodal Treatments for Brain. Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study.. Cancers (Basel). 2023 Feb 22;15(5):1393. doi: 10.3390/cancers15051393.. 2023
    Articolo scientificoCancers (Basel). 2023 Feb 22;15(5):1393. doi: 10.3390/cancers15051393.Leggi il PDF gratuito
15. 15.Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M.. Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?. Neuro Oncol. 2024 Dec 9;26(Supplement_9):S229-S241. doi:10.1093/neuonc/noae192. PMID: 39351771; PMCID: PMC11631097.. 2024
    Articolo scientificoNeuro Oncol. 2024 Dec 9;26(Supplement_9):S229-S241. doi:10.1093/neuonc/noae192. PMID: 39351771; PMCID: PMC11631097.Leggi il PDF gratuito
16. 16.Minniti G, Le Rhun E.. Should radiotherapy be considered for the initial treatment of brain metastases?. Lancet Oncol. 2022 Feb;23(2):205-206. doi:10.1016/S1470-2045(21)00696-3. PMID: 35114118.. 2022
    Articolo scientificoLancet Oncol. 2022 Feb;23(2):205-206. doi:10.1016/S1470-2045(21)00696-3. PMID: 35114118.Leggi il paperCerca versione gratuita
17. 17.Weller M, Remon J, Rieken S, Vollmuth P, Ahn MJ, Minniti G, Le Rhun E, Westphal M, Brastianos PK, Soo RA, Kirkpatrick JP, Goldberg SB, Öhrling K, Hegi-Johnson F, Hendriks LEL.. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape.. Cancer Treat Rev. 2024 Nov;130:102807. doi: 10.1016/j.ctrv.2024.102807. Epub 2024 Aug 2. PMID: 39151281. 2024
    Articolo scientificoCancer Treat Rev. 2024 Nov;130:102807. doi: 10.1016/j.ctrv.2024.102807. Epub 2024 Aug 2. PMID: 39151281Leggi il PDF gratuito
18. 18.Cicone F, Cascini GL, Minniti G. Reply to: "Assessment of imaging biomarkers in the follow-up of brain metastases after SRS".. Neuro Oncol. 2021 Nov 2;23(11):1985-1986. doi: 10.1093/neuonc/noab191. PMID: 34427669; PMCID: PMC8563314.. 2021
    Articolo scientificoNeuro Oncol. 2021 Nov 2;23(11):1985-1986. doi: 10.1093/neuonc/noab191. PMID: 34427669; PMCID: PMC8563314.Leggi il PDF gratuito
19. 19.R Bartsch 1, J M Pérez-García 2, J Furtner 3, A S Berghoff 1, M Marhold 1, A M Starzer 1, M Hughes 4, S Kabraji 5, S Sammons 4, C Anders 6, R K Murthy 7, A E D Van Swearingen 6, A Pereslete 4, M Gion 8, M Vaz Batista 9, S Braga 10, P B C Pinto 11, M Sampayo-Cordero 11, A Llombart-Cussac 12, M Preusser 1, J Cortés 13, N U Lin 14. Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis. ESMO Open. 2025 Jan 3;10(1):104092. doi: 10.1016/j.esmoop.2024.104092. Online ahead of print.. 2025
    Articolo scientificoESMO Open. 2025 Jan 3;10(1):104092. doi: 10.1016/j.esmoop.2024.104092. Online ahead of print.Leggi il PDF gratuito
20. 20.Raymond Y. Huang, MD, PhD1 ; Gilbert Youssef, MD2 ; Thomas Nelson, MD2 ; Patrick Y. Wen, MD2 ; Peter Forsyth, MD3; F. Stephen Hodi, MD4; Kim Margolin, MD5 ; Alain P. Algazi, MD6 ; Omid Hamid, MD7 ; Christopher D. Lao, MD8; Marc S. Ernstoff, MD9 ; Stergios J. Moschos, MD10; Michael B. Atkins, MD11 ; Michael A. Postow, MD12 ; David A. Reardon, MD2 ; Diederik J. Grootendorst, PhD13; David Leung, MD, PhD13; Margarita Askelson, MSc14; Corey Ritchings, PharmD14 ; and Hussein A. Tawbi, MD, PhD15. Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab 1 Ipilimumab in CheckMate 204. DOI https://doi.org/10.1200/JCO.24.00953 Neuro-Oncology Advances 2(1), 1–17, 2020. 2020
    Articolo scientificoDOI https://doi.org/10.1200/JCO.24.00953 Neuro-Oncology Advances 2(1), 1–17, 2020Leggi il PDF gratuito
21. 21.Rakaee M, Tafavvoghi M, Ricciuti B, Alessi JV, Cortellini A, Citarella F, Nibid L, Perrone G, Adib E, Fulgenzi CAM, Murilo Hidalgo Filho C, Di Federico A, Jabar F, Hashemi S, Houda I, Richardsen E, Rasmussen Busund LT, Donnem T, Bahce I, Pinato DJ, Helland Å, Sholl LM, Awad MM, Kwiatkowski DJ.. Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer.. JAMA Oncol. 2024 Dec 26. doi: 10.1001/jamaoncol.2024.5356. Online ahead of print.PMID: 39724105. 2024
    Articolo scientificoJAMA Oncol. 2024 Dec 26. doi: 10.1001/jamaoncol.2024.5356. Online ahead of print.PMID: 39724105Leggi il PDF gratuito
22. 22.Kulasegaran T, Oliveira N.. Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management.. Curr Treat Options Oncol. 2024 Jul;25(7):914-931. doi: 10.1007/s11864-024-01215-2. Epub 2024 Jun 24. PMID: 38913213; PMCID: PMC11236885.. 2024
    Articolo scientificoCurr Treat Options Oncol. 2024 Jul;25(7):914-931. doi: 10.1007/s11864-024-01215-2. Epub 2024 Jun 24. PMID: 38913213; PMCID: PMC11236885.Leggi il PDF gratuito
23. 23.Hatano K, Nonomura N.. Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review.. World J Mens Health. 2023 Oct;41(4):769-784. doi: 10.5534/wjmh.220200. Epub 2023 Jan 27. PMID: 36792090; PMCID: PMC10523115.. 2023
    Articolo scientificoWorld J Mens Health. 2023 Oct;41(4):769-784. doi: 10.5534/wjmh.220200. Epub 2023 Jan 27. PMID: 36792090; PMCID: PMC10523115.Leggi il PDF gratuito
24. 24.Bazyar S, Mannuel H, Tran PT.. Stereotactic ablative radiation therapy in metastatic prostate cancer.. Curr Opin Oncol. 2024 May 1;36(3):180-185. doi: 10.1097/CCO.0000000000001025. Epub 2024 Feb 15. PMID: 38362949; PMCID: PMC10990008.. 2024
    Articolo scientificoCurr Opin Oncol. 2024 May 1;36(3):180-185. doi: 10.1097/CCO.0000000000001025. Epub 2024 Feb 15. PMID: 38362949; PMCID: PMC10990008.Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).